Lavendustin A ≥98%
Lieferant: ENZO LIFE SCIENCES
BMLEI1850001
BMLEI1850005
ENZOBMLEI1850001EA
194
CHF
ENZOBMLEI1850001
ENZOBMLEI1850005
Lavendustin A ≥98%
Lavendustin A
EGFR inhibitor
Cell permeable tyrosine kinase inhibitor with little effect on cAMP-dependent protein kinase (PKA) or protein kinase C (PKC). Potent and selective inhibitor of the EGF receptor tyrosine kinase (IC50=11nM). Binds to a site on the kinase which is distinct from the ATP and peptide substrate binding sites. Inhibits EGF-induced proliferation of cultured human myometrial smooth muscle cells and suppresses VEGF-induced angiogenesis in rats. Effective at 10µM in cultured leech neurons. Also inhibits NMDA-stimulated cGMP production.
Formel:
C₂₁H₁₉NO₆ MW: 381.384 g/mol |
MDL Number:
MFCD00153822 CAS-Nummer: 125697-92-9 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...